Aileron Therapeutics Inc (NASDAQ:ALRN)

2.87
Delayed Data
As of Feb 01
 +0.12 / +4.32%
Today’s Change
1.79
Today|||52-Week Range
15.00
+21.10%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Aileron Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,293.73% increase from the last price of 2.87.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Hold stock in Aileron Therapeutics Inc. This rating has held steady since July, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$1.32
Sales
$0.00
Reporting Date
Apr 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.70%
 
 
 
 
 
 
Growthannually -9.92%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.